Navigation Links
Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting
Date:5/6/2009

e most common cause of retinal reattachment surgery failure still occurring in about 5-12% of cases. Although advances in the surgical management of PVR have improved the ability of surgeons to ultimately reattach the retina, the visual prognosis remains poor, with only 11-25% of patients achieving a visual acuity of 20/100. Presumably this permanent decrease in visual acuity is due, in part, to the loss of photoreceptors since apoptosis is a clear consequence of detachment and can continue at low levels even after the retina is reattached. While there have been numerous attempts to reduce the incidence of PVR, to date no effective pharmacological treatment has been found.

About the PI3K/Akt/mTOR Pathway and Palomid 529

The PI3K/Akt/mTOR pathway has been implicated in a wide variety of biological responses and is considered a major therapeutic target in several different diseases. Activation and subsequent deregulation of this signaling pathway, via direct or indirect mutagenic events, is common in many types of human diseases. Thus, agents capable of inhibiting the pathway are attractive targets for therapeutic intervention. Central to the signalling pathway are two distinct protein complexes, one of which, TORC1, regulates cell growth by acting on the signal transduction protein S6K, while the other, TORC2, regulates cell survival through Akt. These complexes define the rapamycin-sensitive and insensitive branches of the PI3K/Akt/mTOR pathway. Inhibitors of TORC2 may have beneficial effects without toxicity to normal tissues since loss of TORC2 in genetically altered mice does not appear to affect normal tissue. TORC1 antagonists such as rapamycin (Sirolimus) have shown activity in both animal models of ocular disease and in human clinical trials. The inhibition of both TORC1 and TORC2 should result in more complete inhibition of aberrant PI3K/Akt/mTOR signaling and are therefore of active interest for pharmaceutical
'/>"/>

SOURCE Paloma Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
2. Transcept Pharmaceuticals to Report First Quarter 2009 Results
3. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
4. Potentia Pharmaceuticals POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II
5. Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology
6. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
7. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
8. Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients
9. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
10. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
11. Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)...  Decision Resources Group finds that the market for interventional ... remain relatively stagnant at a value of around $80 million ... intervention (PCI) volumes are growing faster in Canada ... the United States and Europe ... increase in penetration of PCI procedures relative to coronary artery ...
(Date:7/22/2014)... According to a new ... (Technology Types - Near infrared (NIR) spectroscopy, Raman spectroscopy and ... Size, Share, Growth, Trends and Forecast, 2013 - 2019," the ... is expected to grow at a CAGR of 7.4% from ... was the largest contributor to global process spectroscopy market ...
(Date:7/22/2014)... , July 22, 2014  Eyeon Therapeutics has received ... treatment based on a charged hydrophilic polymer developed at ... has been shown to be safe and effective in ... MD, CEO states, "This first set of claims around ... way to moving this technology into the commercial phase.  ...
Breaking Medicine Technology:The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 2Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 4Particle Sciences and Eyeon Therapeutics Receive Patent on Novel Dry Eye Technology 2
... 12, 2011 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... on August 29, 2011, as Vice President, Finance and Chief ... Arena for over 13 years before departing in March to ... a valuable leader who has been a key contributor to ...
... 2011 5 modules - 2 weeks - ... to announce that the Stability Testing Online Training Course is proving ... ,The secret behind the Stability testing Online Training Course ... is its user-friendly format which allows flexible and interactive high standard, ...
Cached Medicine Technology:Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer 2Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer 3Stability Testing Course is Taking the Online Training Format by Storm! 2
(Date:7/22/2014)... on Lung Cancer (LALCA 2014) will be held August ... Cancer is still the leading cause of death not ... success of the previous conferences in Chile, Mexico, Argentina ... science and advances in the treatment and prevention of ... in particular. , With tobacco being the leading cause ...
(Date:7/22/2014)... Ticket Down is a reliable source for cheap ... Landover, MD. There has never been a better time in ... the success of the American national soccer team at the 2014 ... way that fans of the world’s sport will be able to ... International Champions Cup. The tournament will kick off on July 24 ...
(Date:7/22/2014)... 22, 2014 The Entertainment Industries Council, ... resources, educational tools and recognition activities for thousands of ... prevention, treatment and recovery. On July 24, 2014, at ... some of these resources with a special mention of ... and treatment website at the end of the show. ...
(Date:7/22/2014)... London, UK (PRWEB) July 22, 2014 ... considerably over the past few years, owing to novel ... performed with BoNTs in the aging societies where physical ... is led by one player, current competitors, new companies ... for biosimilars. As biosimilar BoNTs will put the price ...
(Date:7/22/2014)... HealthDay Reporter TUESDAY, July 22, 2014 ... procedure known as morcellation carries a risk of spreading undetected ... clearly. Twenty-seven of every 10,000 women who had the ... procedure, researchers found, with the odds being highest for patients ... with morcellation use a power cutter to slice uterine tissue ...
Breaking Medicine News(10 mins):Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 2Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 3
... of Families with Deployed Service Members ... ... $15,000 to the Missouri National Guard -,Missouri Military Family Relief Fund, which will ... Don Brown, market vice president for the central market area at,TriWest, will ...
... Sutter Regional Medical,Foundation,s newly completed third building on ... to a full-range of,state-of-the-art health care services in ... center, located at 2720 Low,Court, replaces the 1234 ... for growth. Designed with comfort and healing in ...
... healthy foods early and often works, research suggests , , MONDAY, ... to love fruits and veggies later in life, offer plenty ... to solid foods, new research suggests. , And mom, eat ... so you,ll help to pass on the preference for these ...
... Ohio, Dec. 3 Seniors who take a close ... Advantage plans may reap,handsome savings next year. Many Medicare ... premiums and $0 deductibles with either complete or,partial coverage ... of their drug bills until reaching $4,050 in out-of-pocket ...
... watery eyes,are often attributed to the common cold, but ... American Academy of Allergy, Asthma &,Immunology (AAAAI)., "Millions ... during the,winter months when they,re actually experiencing allergies," said ... and,allergy symptoms can be very similar, making it hard ...
... services for, at-risk and low-income students to prevent critical health ... ... 3 Approximately 117,000 of Oregon,s,children are uninsured, leaving them ... illness and help them stay in,school. At-risk and low-income children ...
Cached Medicine News:Health News:TriWest Contributes $15,000 to Missouri National Guard Fund 2Health News:Sutter Regional Medical Foundation Opens New Fairfield Care Center 2Health News:Want to Raise a Fruit-and-Veggie Lover? Be Persistent 2Health News:Want to Raise a Fruit-and-Veggie Lover? Be Persistent 3Health News:Want to Raise a Fruit-and-Veggie Lover? Be Persistent 4Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2008 Out-of-Pocket Drug Costs 2Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2008 Out-of-Pocket Drug Costs 3Health News:Your Stuffy Nose Could Mean More Than a Cold 2Health News:Regence Partners with Multnomah Education Service District to Bring Free Health Services to more than 20,000 Students in Need 2Health News:Regence Partners with Multnomah Education Service District to Bring Free Health Services to more than 20,000 Students in Need 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: